Related Experiment Video
Updated: Dec 29, 2025
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.7K
Not Yet Another Negative Trial-ReACTing on Recent Glioblastoma Trials
Wolfgang Wick1, Robin J Wagener2
1University Medical Center & German Cancer Research Center, Heidelberg, Germany. wolfgang.wick@med.uni-heidelberg.de.
Abstract:
The present ReACT trial provides data from a small randomized controlled vaccination trial that in addition to other recent immunotherapy trials in glioblastoma allows sketching a rational, advanced trial design for the development of (immune) therapies in glioblastoma elaborating on but not restricting to biological monitoring and endpoints.See related article by Reardon et al., p. 1586.
